News Category
Earth Science Tech Inc. is building a scalable healthcare business through vertical integration and a dual B2B/B2C model, with plans to expand its geo...
New research presented at the American Heart Association's Hypertension Scientific Sessions 2026 shows that masked hypertension—normal office blood pr...
As dental implant costs continue to rise, patients must understand complete treatment plans, insurance, and financing to achieve affordable, quality c...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's clinical research business to execute a Phase 2 trial of Lucid-MS, a nove...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies across its preclinical programs, potentially accelerating clinical advancement, ...
SS Innovations International is advancing telerobotic surgery with its SSi Mantra system, reporting 195 telesurgeries and a 45% increase in installed ...
Lantern Pharma's Taiwan regulatory and IRB approvals for the Phase 2 HARMONIC trial of LP-300 enable expansion of a biomarker-driven study targeting E...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business to launch a Phase 2 trial of Lucid-MS signals a potential paradigm shift...
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies to reduce animal testing, accelerate clinical advancement, and cu...
Dutchess Orthodontics outlines key criteria families should use when choosing a braces provider, emphasizing early intervention, treatment options for...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business marks a critical step toward testing a first-in-class neuroprotective th...
XORTX Therapeutics is positioning its proprietary gout treatment XORLO for a New Drug Application submission to the FDA within a year, aiming to addre...
C60 Power's National C60 Day on October 9 spotlights the 1996 Nobel Prize in Chemistry for fullerenes and the expanding consumer market for Carbon 60 ...
C60 Power's National C60 Day highlights the discovery of buckminsterfullerene and the growing consumer interest in Carbon 60 research and products.
Braces Now has added digital scanning technology and a full range of orthodontic treatments, including braces and Invisalign, at its Buford, Georgia o...
Dr. Judith A. Swack, originator of the Healing from the Body Level Up™ methodology, explains why people remain stuck in old emotional patterns despite...
Quantum BioPharma has entered a Study Start-Up Agreement with Thermo Fisher Scientific to initiate its Phase 2 trial of Lucid-MS for multiple sclerosi...
Telomir Pharmaceuticals raised approximately $5.6 million in a PIPE financing that will fund clinical development of Telomir-Zn, including a Phase 1/2...
Earth Science Tech's real estate arm Avenvi LLC provides both physical infrastructure for its pharmacy operations and asset management services, highl...
NanoViricides' upcoming presentation at the NIBA 153rd Investment Conference highlights its progress on NV-387, a broad-spectrum antiviral in Phase 2 ...
Quantum BioPharma's Study Start-Up Agreement with Thermo Fisher's clinical research business marks a critical step toward launching a Phase 2 trial fo...
A new study reveals lymph-node-like structures in the skull's bone marrow that may serve as a local immune defense for the brain, potentially opening ...
Okogen's CDSCO authorization for the EMERALD Phase 1/2 study of Treyegen (OKG-0303) marks a significant step toward a single therapy for viral and bac...
Kairos Pharma's Phase 2 trial of ENV-105 in metastatic castration-resistant prostate cancer demonstrates a median PFS of 17.7 months versus 2 months f...
AXIM Biotechnologies' 510(k) submission for a next-generation tear lactoferrin test could bring objective, 10-minute dry eye diagnosis directly into e...
GeoVax's upcoming presentation at World Vaccine Congress Europe 2026 will detail its next-generation MVA-X vaccine and continuous cell-line manufactur...
The Hong Kong Convention and Exhibition Centre hosted 786 events in FY 2025–2026, including 25 new exhibitions and conferences, and has confirmed the ...
BFCH and NEXT10 are advancing a strategy to build UNLOCKD into a scalable health, wellness and longevity platform, targeting five to seven consumer br...
Author Lawyer Johnson is offering 100 Kindle copies of his memoir 'My Pain Is My Identity' through a Goodreads giveaway, drawing attention to his mess...
Market Street Capital's capital markets discipline offers middle-market healthcare companies a way to structure financings amid reimbursement uncertai...
NHS England's new intraoperative brain tumor test, developed at the University of Nottingham, reduces genetic diagnosis time from eight weeks to two h...
NanoViricides has initiated a Phase II clinical trial of its oral NV-387 gummies for Ebola, a potential breakthrough for outbreak response in resource...
HeartBeam Inc. (NASDAQ: BEAT) received FDA Breakthrough Device Designation for its HeartBeam System, which could enable at-home heart attack assessmen...
CCHR International marks Mental Health Awareness Week by releasing an updated Mental Health Declaration of Human Rights and urging Americans to sign a...
Well Adjusted Chiro Cleveland's 2026 patient-education campaign helps residents prepare for spinal adjustment consultations by organizing questions an...
SS Innovations International is scaling its SSi Mantra robotic surgery system from India into international markets, with strong revenue growth and re...
Redwood AI Corp. has been named a co-applicant in a Terry Fox Research Institute grant to develop Onco-Innovations' SynoGraph™ platform, aiming to use...
A new blood-based method for identifying cancer-specific proteins could make personalized immunotherapy faster and more accessible for patients who ca...
The release of two billion pounds of cancer-linked chemicals into U.S. air in 2020 underscores the urgent need for both stronger prevention policies a...
Quantum BioPharma's Lucid-MS is entering a Phase 2 trial in multiple sclerosis patients, marking a significant milestone for the company and potential...
Dr. Annet Kirabo will receive the American Heart Association's 2026 Joseph A. Vita Award for her paradigm-shifting research linking immune activation ...
Viromed Medical AG reported progress in product development and market launch in H1 2026, including regulatory approval for ViroCAP med and a new sale...
Novogenia AG's H1 2026 report shows a 7% revenue decline but positive growth in DNA analysis and personalized health products, alongside strategic pro...
Redcare Pharmacy raised its full-year 2026 revenue guidance for the second time this year, driven by stronger-than-expected prescription drug growth i...
Nanox is assembling an integrated imaging platform to extend advanced diagnostics to underserved settings, addressing a severe global access gap and b...
Regentis Biomaterials' GelrinC hydrogel implant represents a paradigm shift from symptom management to structural repair in knee cartilage care, with ...
Regentis Biomaterials is developing GelrinC, a cell-free hydrogel implant that supports the orthopedic field's move from symptom management to early s...
Scientists in South Korea have discovered a key protein that regulates brain cancer growth, potentially leading to new treatments for glioblastoma, th...
